Nu Skin Enterprises (NYSE:NUS) Releases FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUSGet Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.900-1.300 for the period, compared to the consensus earnings per share estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Up 1.3 %

Shares of NUS opened at $6.41 on Friday. The firm has a market cap of $318.39 million, a P/E ratio of -3.09 and a beta of 1.17. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $17.68. The firm’s 50-day simple moving average is $6.91 and its 200 day simple moving average is $7.50.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. On average, analysts forecast that Nu Skin Enterprises will post 0.68 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on NUS. Citigroup decreased their price target on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd. DA Davidson reduced their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th. Finally, StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th.

View Our Latest Research Report on NUS

About Nu Skin Enterprises

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.